**Core Concept**
The **liver** plays a crucial role in drug metabolism, and **cirrhosis** can significantly alter this process. Drugs that are heavily metabolized by the liver may require dose adjustments in patients with cirrhosis to prevent toxicity.

**Why the Correct Answer is Right**
Since the correct answer is not explicitly provided, let's discuss the general principle. Drugs that are primarily excreted by the **kidneys** or have a wide therapeutic index may not require dose reduction in cirrhosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Would be incorrect if it's a drug that's heavily metabolized by the liver.
**Option B:** Similarly, if it's a liver-metabolized drug, it would be incorrect.
**Option C:** This option would be incorrect if the drug requires liver metabolism.

**Why Each Wrong Option is Incorrect (Continued)**
**Option D:** Assuming this is the correct answer, it might be a drug that doesn't require liver metabolism for excretion or has a different pharmacokinetic profile.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **drug dosing in cirrhosis** often requires careful consideration of the liver's metabolic capacity.

**Correct Answer:** Correct Answer: D. Morphine